Logotype for Aspo Oyj

Aspo (ASPO) Q2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Aspo Oyj

Q2 2024 earnings summary

1 Feb, 2026

Executive summary

  • Q2 2024 net sales rose 16% year-over-year to EUR 153.5 million, with all business segments improving profitability and comparable EBITA more than doubling to EUR 7.4 million, driven by organic growth, acquisitions, and vessel sales.

  • Strategic execution included the sale of two Supramax vessels, launch of Green Coaster vessels, and major acquisitions by Telko and Leipurin in Germany, Sweden, Benelux, and France.

  • A 21.43% minority stake in ESL Shipping was sold for EUR 45 million, strengthening the balance sheet.

  • Aspo announced a new portfolio vision to form two separate companies and set a 2028 ambition of EUR 1 billion in net sales and 8% EBITA margin.

Financial highlights

  • Q2 2024 net sales: EUR 153.5 million (Q2 2023: EUR 132.5 million); H1 2024: EUR 286.2 million (H1 2023: EUR 274.2 million).

  • Comparable EBITA for Q2: EUR 7.4 million (Q2 2023: EUR 3.9 million); H1: EUR 12.4 million (H1 2023: EUR 12.6 million), despite EUR 4.2 million in strike/weather impacts and EUR 2.5 million in M&A costs.

  • Free cash flow in Q2: EUR 22.9 million (Q2 2023: EUR 15.1 million); H1: EUR 26.4 million (H1 2023: EUR 5.9 million).

  • EPS for Q2: EUR 0.07 (Q2 2023: EUR -0.19); comparable EPS: EUR 0.09 (Q2 2023: EUR 0.05).

  • Net debt at period end: EUR 119.6 million (12/2023: EUR 165.2 million); net debt to EBITDA: 2.0.

Outlook and guidance

  • 2024 guidance unchanged: comparable EBITA expected to exceed EUR 32 million (2023: EUR 27.9 million), driven by Green Coaster vessels, Telko acquisitions, and profit improvement actions.

  • Market recovery is expected to be delayed, with limited positive impact in H2 2024; focus on integrating acquisitions and cost actions.

  • ESL Shipping expects stable steel industry demand and gradual recovery in forest industry; Telko anticipates stable but slow market improvement; Leipurin faces continued deflation but sees growth in the food industry.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more